ATE368450T1 - Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält - Google Patents

Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält

Info

Publication number
ATE368450T1
ATE368450T1 AT99958096T AT99958096T ATE368450T1 AT E368450 T1 ATE368450 T1 AT E368450T1 AT 99958096 T AT99958096 T AT 99958096T AT 99958096 T AT99958096 T AT 99958096T AT E368450 T1 ATE368450 T1 AT E368450T1
Authority
AT
Austria
Prior art keywords
hfa
preparation containing
pharmaceutical aerosol
aerosol preparation
inhaler
Prior art date
Application number
AT99958096T
Other languages
English (en)
Inventor
David Lewis
David Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE368450T1 publication Critical patent/ATE368450T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99958096T 1998-11-25 1999-11-22 Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält ATE368450T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002558A IT1303788B1 (it) 1998-11-25 1998-11-25 Formulazioni di aerosol medicinali.

Publications (1)

Publication Number Publication Date
ATE368450T1 true ATE368450T1 (de) 2007-08-15

Family

ID=11381136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958096T ATE368450T1 (de) 1998-11-25 1999-11-22 Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält

Country Status (22)

Country Link
US (2) US6713047B1 (de)
EP (1) EP1133277B1 (de)
JP (1) JP2002530316A (de)
KR (1) KR100794060B1 (de)
CN (1) CN1177582C (de)
AT (1) ATE368450T1 (de)
AU (1) AU770529B2 (de)
BR (1) BR9916865A (de)
CA (1) CA2352483C (de)
CY (1) CY1106904T1 (de)
DE (1) DE69936730T2 (de)
DK (1) DK1133277T3 (de)
ES (1) ES2289832T3 (de)
IL (1) IL143293A0 (de)
IT (1) IT1303788B1 (de)
MA (1) MA26763A1 (de)
NO (1) NO330195B1 (de)
NZ (1) NZ511923A (de)
PT (1) PT1133277E (de)
TR (1) TR200101442T2 (de)
WO (1) WO2000030607A1 (de)
ZA (1) ZA200104220B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1248597B1 (de) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
US20060257324A1 (en) 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
GB2367011A (en) * 2000-08-26 2002-03-27 Glaxo Group Ltd Metered dose inhaler for salmeterol
DE60103527T2 (de) * 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340503A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Lösung Aerosol Formulierung von Estern von 3,17-dihydroxy Oestratrien-Derivaten zur Lungenverabreichung
EP1415647A1 (de) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. Langwirkende beta-2-Agonisten in ultrafeiner Formulierung
IL163843A0 (en) * 2002-03-01 2005-12-18 Chiesi Farma Spa Formoterol superfine formulation
EP1340492A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
EP1369113B1 (de) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
EP1452179A1 (de) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid
EP1915985A1 (de) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulierung für einen Dosierinhalator mit Hydrofluoralkanen als Treibstoffen
ME00420B (me) 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
RU2364400C2 (ru) * 2003-04-14 2009-08-20 Вектура Лтд Фармацевтические композиции
AU2004272077A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
IL177103A0 (en) * 2004-02-27 2006-12-10 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1595531A1 (de) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
CN1583170A (zh) * 2004-06-10 2005-02-23 安米 用于抗病毒抗耐药菌的人溶菌酶药物及其制法
BRPI0512878A (pt) 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP2011534A1 (de) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Aktuator für einen Inhalator für abgemessene Dosen
WO2011150441A1 (en) * 2010-06-03 2011-12-08 Wholesome Biopharm Pty Ltd Medical aerosol formulation comprising ribavirin
EP3143987A1 (de) * 2010-08-03 2017-03-22 CHIESI FARMACEUTICI S.p.A. Pharmazeutische formulierung mit einem phosphodiesterasehemmer
WO2014205030A1 (en) * 2013-06-19 2014-12-24 Map Pharmaceuticals, Inc. Pulmonary administration of rotigotine
US20160310410A1 (en) 2015-04-24 2016-10-27 Glenmark Specialty S.A. Pharmaceutical compositions comprising arformoterol and glycopyrronium
CN114796166A (zh) * 2021-01-29 2022-07-29 北京远大九和药业有限公司 一种含有萜烯类挥发油的气雾剂及其制备方法
CN114522143B (zh) * 2022-02-22 2026-02-06 暨南大学 用于吸入气雾剂的低制冷效应复合抛射剂及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH89518A (de) * 1919-03-22 1921-06-01 Croning Johannes Der Türdicke entsprechend einstellbares Gehäuse für Zylinderschlösser.
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
US3860618A (en) * 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
AU658854B2 (en) 1990-10-18 1995-05-04 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
SI0820279T1 (en) * 1995-04-14 2002-12-31 Smithkline Beecham Corporation Metered dose inhaler for albuterol
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
EP0914143A1 (de) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medizinische aerosollösungsformulierungen mit cyclosporin-a
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP1340492A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
EP1415647A1 (de) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. Langwirkende beta-2-Agonisten in ultrafeiner Formulierung
IL163843A0 (en) * 2002-03-01 2005-12-18 Chiesi Farma Spa Formoterol superfine formulation

Also Published As

Publication number Publication date
CY1106904T1 (el) 2012-05-23
WO2000030607A8 (en) 2001-03-22
CN1177582C (zh) 2004-12-01
ITMI982558A1 (it) 2000-05-25
KR20010080560A (ko) 2001-08-22
NZ511923A (en) 2003-10-31
NO20012517D0 (no) 2001-05-22
AU1555300A (en) 2000-06-13
US20040184993A1 (en) 2004-09-23
TR200101442T2 (tr) 2002-05-21
EP1133277B1 (de) 2007-08-01
WO2000030607A1 (en) 2000-06-02
AU770529B2 (en) 2004-02-26
MA26763A1 (fr) 2004-12-20
BR9916865A (pt) 2001-11-13
PT1133277E (pt) 2007-10-09
ZA200104220B (en) 2002-05-23
IL143293A0 (en) 2002-04-21
NO330195B1 (no) 2011-03-07
CN1331581A (zh) 2002-01-16
DE69936730T2 (de) 2008-04-30
NO20012517L (no) 2001-07-23
DE69936730D1 (de) 2007-09-13
JP2002530316A (ja) 2002-09-17
US6713047B1 (en) 2004-03-30
KR100794060B1 (ko) 2008-01-10
EP1133277A1 (de) 2001-09-19
DK1133277T3 (da) 2007-12-27
ES2289832T3 (es) 2008-02-01
IT1303788B1 (it) 2001-02-23
CA2352483A1 (en) 2000-06-02
CA2352483C (en) 2009-01-20

Similar Documents

Publication Publication Date Title
DE69936730D1 (de) Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält
Steckel et al. In vitro evaluation of dry powder inhalers I: drug deposition of commonly used devices
MXPA02011414A (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis.
Maggi et al. Influence of the moisture on the performance of a new dry powder inhaler
TNSN04148A1 (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
BR9406908A (pt) Composição farmacêutica dispositivo inalador processo para administração sistema de um polipeptideo farmaceuticamente ativo para a fabricação e preparação de uma composição farmacêutica e uso de um agente de melhoramento na preparação de uma preparação de po seco inalavel
NZ334149A (en) Pharmaceutical aerosol composition containing an active material, a propellant containing a hydrofluoroalkane and a cosolvent and a low volatility component
KR970704422A (ko) 투여용 약제학적 조성물
IS4178A (is) Lyfjablanda til innöndunar sem inniheldur insúlín
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
ATE128350T1 (de) Pharmazeutische aerosolformulierung.
AU4260496A (en) Propellant mixture for aerosol formulation
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
AR009370A1 (es) UNA COMPOSICION FARMACEUTICA EN AEROSOL ADECUADA PARA LA ADMINISTRACION DE BUDESONIDA, UN PRODUCTO FARMACEUTICO QUE LA CONTIENE, UN METODO PARAADMINISTRAR BUDESONIDA Y USO DE UNA MEZCLA DE HFA 134a Y HFA 227
ATE402727T1 (de) Pulverinhalator
AU2512801A (en) Aerosol inhaler
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
JP2004529108A5 (de)
YU87902A (sh) Stabilne farmaceutske formulacije rastvora za inhalatore odmerene doze pod pritiskom
GEP20053649B (en) Stable Pharmaceutical Solution Formulations for Pressurised Metered Dose Inhalers

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1133277

Country of ref document: EP